Welcome to LookChem.com Sign In|Join Free

CAS

  • or

24246-07-9

Post Buying Request

24246-07-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24246-07-9 Usage

Molecular class

Pyrazole derivatives

Usage

Pharmaceutical industry (synthesis of various drugs and building block in organic synthesis)

Chemical structure

Pyrazole ring with a phenyl group and a methyl ester

Biological activities

Potential bioactive molecules synthesis starting material

Check Digit Verification of cas no

The CAS Registry Mumber 24246-07-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,2,4 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24246-07:
(7*2)+(6*4)+(5*2)+(4*4)+(3*6)+(2*0)+(1*7)=89
89 % 10 = 9
So 24246-07-9 is a valid CAS Registry Number.

24246-07-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(5-oxo-1-phenyl-4H-pyrazol-3-yl)acetate

1.2 Other means of identification

Product number -
Other names methyl (5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24246-07-9 SDS

24246-07-9Relevant articles and documents

PYRAZOLONE DERIVATIVE HAVING CYCLIC SIDE CHAIN

-

Paragraph 0414; 0415, (2016/10/08)

PROBLEM TO BE SOLVED: To provide a compound that has excellent inhibitory action on ATPase activity of TIP48/TIP49 complex and is therefore useful for the treatment of tumor, or a pharmacologically acceptable salt thereof. SOLUTION: The present invention provides a compound having a structure represented by general formula (I), its pharmacologically acceptable salt, or a pharmaceutical composition comprising the compound (where R1, R2, R3, R4, R5, R6, R7, W, and Z are as defined in the specifications). SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

Transformations of alkyl (5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)acetates into 5-heteroaryl-3-oxo-2-phenyl-3,5-dihydro-2H-pyrazolo[4,3-c] pyridine-7-carboxylates

Bevk, David,Jak?e, Renata,Svete, Jurij,Golobi?, Amalija,Goli?, Ljubo,Stanovnik, Branko

, p. 197 - 223 (2007/10/03)

Alkyl [(Z)-4-dimethylaminomethylidene-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl] acetate (4) was transformed with N- and C-nucleophiles into alkyl [4-(substituted amino)methylidene-4,5-dihydro-1H-pyrazol-3- yl] acetates (7) and alkyl (4-heteroarylmethylidene-4,5-dihydro-1H -pyrazol-3-yl)acetates (8), respectively. Compounds (7) cyclize by heating with DMFDMA in DMF into 2H-pyrazolo[4,3-c]pyridine-7-carboxylates (9).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24246-07-9